Aimei Health Technology AFJK
NASDAQ AFJK
$12.56 +0.23 (+1.87%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aimei Health Technology (AFJK) Income towards Parent Company (2024 - 2025)

Aimei Health Technology (AFJK) posted quarterly Income towards Parent Company of -$130152.0 for Q3 2025, up 34.93% year-over-year from -$96458.8 in Q3 2024, and down 212.84% quarter-over-quarter from -$41604.0 in Q2 2025.

Aimei Health Technology (AFJK) Income towards Parent Company (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has reported Income towards Parent Company for 2 consecutive years, with -$130152.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Income towards Parent Company rose 34.93% year-over-year to -$130152.0; the TTM figure through Dec 2025 stood at -$585170.0 (up 45.04% YoY), while the FY2024 annual figure was -$1.1 million, down 3641.47% from the prior year.
  • Income towards Parent Company retreated to -$130152.0 in Q3 2025 per AFJK's latest filing, from -$41604.0 in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$41604.0 in Q2 2025 and bottomed at -$413414.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn -
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn -
6 Aldel Financial 397.49 Mn 397.49 Mn -
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn -
8 Gores Holdings X 385.06 Mn 384.87 Mn -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn -
10 Aimei Health Technology 50.90 Mn 50.89 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -130,152.00
Jun 30, 2025 -41,604.00
Mar 31, 2025 -413,414.00
Dec 31, 2024 -402,021.00
Sep 30, 2024 -200,019.00
Jun 30, 2024 -309,114.00
Mar 31, 2024 -153,632.00